
AMD is a serious eye disease and the leading cause of vision loss in people older than 50. About 18 million people in the US have dry AMD. It affects sharp, central vision andlthe ability to see fine details.
Dry AMD affects the retinal cells of your eye, causing them to slowly break down. The retina is a thin, light-sensitive structure in the back of the eye that acts like a sensor. Its job is to capture light and convert it into signals that are sent to the brain.

Blurry vision while reading, driving, or watching TV
Colors are harder to distinguish
Visual distortions, such as straight lines, seem bent
Trouble adjusting to dim light
Dry AMD can get worse without treatment, eventually leading to permanent vision loss.

EARLY
Presence of small or medium-sized yellow or white spots on the back of one or both eyes

INTERMEDIATE
Presence of many medium-sized spots or a large spot

ADVANCED (geographic atrophy)
Eye tissues slowly wears away, which leads to loss of vision

The FIRST AND ONLY FDA-authorized treatment
for dry AMD to improve and maintain vision at about 2 years.
Valeda™ PBM uses a light-based therapy called photobiomodulation (PBM) to help stimulate energy production in the cells of your eyes.
Treatments are given at your doctor's office or clinic and and may take 10 minutes or less to complete.
Valeda™ PBM is noninvasive, which means there are no needles; only light is used
Your pupils are not dilated, and there is no anesthesia. This means you are free to carry on with your daily activities after treatment.
With the flexibility of Valeda™ PBM treatments, you have more freedom to experience the moments that matter.

Talk to your doctor about how Valeda™ PBM can improve and maintain your vision so that you don't miss the moments that matter.